Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster presentations ...
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule ...
This 2025 guide features leading specialists in geriatrics, cardiology, oncology, cosmetic dentistry and cutting-edge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback